The effectiveness of mitral valve surgery in patients with open heart surgery in Samut Sakhon hospital

Authors

  • Nuttapong Ruaman Surgery Department, Samut Sakhon Hospital

Abstract

The mitral valve surgery consists of mitral valve repair and mitral valve replacement. The option depends on the pathology of mitral valve disease. The primary outcome were surgical outcome, early mortality in 30 days and complication in mitral valve surgery. The secondary outcome were the comparison of the result of mitral valve surgery between mitral valve repair and mitral valve replacement, postoperative results and complications.

In this descriptive study, the studied group consisted of 59 patients undergoing mitral valve repair and 64 patients undergoing mitral valve replacement who receive mitral valve surgery (Total 120 patients) in Samut Sakhon hospital. The patients were recruited from the medical record since 1 January 2019 to 30 April 2022. The statistics used for analysis of the data were frequency, percentage, mean, standard deviation, Chi-square test and Independent sample T-test.

There were 7 (5.70%) patients of mitral valve surgery with death in 30 days, There was no significant difference between 3 (5.08%) patients of mitral valve repair and 4 (6.25%) patients of mitral valve replacement. There were 11 (8.95%) patients with acute kidney injury (AKI) and required hemodialysis 1 (0.80%) patient. The postoperative complication consisted of low cardiac output syndrome 8 (6.50%) patients, postoperative stroke 3 (2.40%) patients, postoperative VF/VT 1 (0.80%) patient and postoperative heart block 1 (0.80%) patient.

The effectiveness of mitral valve surgery can be safely performed in patients with mitral valve disease with low postoperative morbidity and mortality rates. The decision to operate the patients depends on the patient’s condition, surgical finding and experience before surgery.

References

Joanna chikwe, Cooke D, Weiss A. Oxford Specialist Handbook of Cardiothoracis Surgery. second ed. Oxford University Press 2013. 845 p.

Cohn LH, Adams DH. Cardiac Surgery in the Adult Fifth Edition: McGraw-Hill Education; 2017.

Sellke FW, Nido PJD, Swanson SJ. Sabiston & Spencer Surgery of the Chest: Elsevier; 2015.

Anyanwu AC, Adams DH. Etiologic classification of degenerative mitral valve disease: Barlow's disease and fibroelastic deficiency. Seminars in thoracic and cardiovascular surgery. 2007;19(2):90-6.

Nishimura RA, Vahanian A, Eleid MF, Mack MJ. Mitral valve disease--current management and future challenges. Lancet (London, England). 2016;387(10025):1324-34.

Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation. 1985;72(6):1155-62.

Massell BF, Chute CG, Walker AM, Kurland GS. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. The New England journal of medicine. 1988;318(5):280-6.

Downloads

Published

2022-08-30

How to Cite

1.
Ruaman N. The effectiveness of mitral valve surgery in patients with open heart surgery in Samut Sakhon hospital. Phahol Hosp J [internet]. 2022 Aug. 30 [cited 2025 May 12];11(32):19-2. available from: https://he04.tci-thaijo.org/index.php/PPHJ/article/view/965

Issue

Section

Original Articles